Michael Lee Brooks is COO at Syneos Health, Inc. (SYNH). They have made 3 open-market trades across 1 company since 2021, most recently 2023-09-28.
CIK 0001892101
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SYNH | 107,127 | $4.6M |
Shares reported on the most recent Form 4, priced at the 2023-09-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SYNH | SELL | 2022-07-28 | 2022-07-29 | $78.00 | $117K | -11.3% | -22.1% | -37.2% |
| SYNH | SELL | 2022-07-21 | 2022-07-22 | $76.00 | $114K | -11.8% | -14.4% | -38.6% |
| SYNH | SELL | 2022-07-19 | 2022-07-20 | $74.00 | $111K | +5.2% | -12.2% | -35.0% |
| SYNH | SELL · 10b5-1 | 2021-12-30 | 2022-01-03 | $103.00 | $10K | -6.8% | -7.2% | -16.9% |
| SYNH | SELL · 10b5-1 | 2021-12-22 | 2021-12-23 | $99.00 | $9K | -7.3% | -13.2% | -22.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.